New drug for Macular Degeneration

Genetech is currently studying a new drug, lampalizumab, to treat age-related macular degeneration. The drug is designed to slow the destruction of light-sensing cells in the retina. When those cells die, they are unable to regenerate, which causes permanent vision loss. 129 patients participated in the 18-month study and received monthly eye injections. The patients […]

Study warns of unregulated clinics

A recent study published in the journal Cell¬†warns of a growing number of unregulated clinics in the United States offering unregulated stem cell treatments. This alarming trend has eye care professionals urging consumers to be on alert. The unregulated clinics are able to skirt FDA oversight all because of a technicality. These clinics take cells […]

Eye disease screening recommendations

Adults who have no signs or risk factors for eye disease should get a baseline eye disease screening at age 40 according to recommendations by the American Academy of Ophthalmology. Age 40 is the age when early signs of eye disease and vision changes might begin to occur. The baseline screening will allow the ophthalmologist […]

#1 Cause of Vision Loss in Adults? Diabetes.

Diabetic retinopathy is the #1¬†cause of vision loss among working adults between the ages of 20 and 74 in the United States.* Lucentis recently gained FDA approval for monthly treatment of every form of diabetic retinopathy. This marks the first drug that the FDA has approved to treat diabetic retinopathy “with or without diabetic macular […]

Discontinuing macular degeneration injections results in vision loss

A retrospective, observational study examined the data from 35 patients who had received anti-VEGF injections of the eye for treatment of the wet form of macular degeneration but then stopped treatment despite continued symptoms. Researchers found a notable deterioration in visual acuity over two years. Researchers looked at the best-corrected visual acuity (BCVA) at the […]

Eye injections increase glaucoma risk

Patients who receive seven or more Intravitreous eye injections of bevacizumab (Avastin) each year are at a higher risk of eventually needing glaucoma surgery according to study results recently published in the JAMA Ophthalmology medical journal. Intravitreous injections are the standard therapy for patients suffering from the wet form of macular degeneration. Researchers examined data […]

Which sport causes most eye injuries?

In my practice, you’d be surprised by the answer. And since April is the American Academy of Ophthalmology’s Sports Safety Month, it’s important to think about protecting your eyes when playing. Now that the March Madness college basketball championship is over (boo hoo for my University of Michigan team), you’ll want to be aware that […]

Some unproven stem cell treatments can cause blindness

Stem cell therapy is a hot topic in the news and the hope that stem cell therapy provides as a potential treatment for macular degeneration has resulted in clinics across the country providing unproven treatments. Recently, three elderly women underwent an unapproved stem cell therapy at a Florida clinic and within a week of receiving, […]

Tiny eye implant may help blind people

Researchers at the University of California, San Diego have developed a high-resolution retinal prosthesis that uses nanowires and wireless electronics to assist neurons in the retina in responding to light. The device will aid people suffering from eye diseases such as macular degeneration, and retinitis pigmentosa. This new device differs from current retinal prostheses in […]

Americans’ Greatest Health Fear? Going Blind

A study conducted by the Wilmer Eye Institute at Johns Hopkins University School of Medicine found that most Americans deem loss of vision as the worst thing that could happen to them even when compared to memory loss, loss of speech, hearing or loss of limb or having HIV/AIDS. Despite the fact that most Americans […]